Innovation

Reduced and Quaternized Psoralens as Photo-Activated Therapeutics (Technology#: 090294-01)

Lehigh University Office of Technology Transfer
posted on 04/23/2009

The invention features phototherapeutic compositions comprising Type 1, Type 2, or Type 3 psoralens and methods of using such compounds for treatment of proliferative diseases of skin, blood and bone marrow.


APPLICATIONS
  • photosensitization
  • photochemotherapy
  • photopheresis

STATUS OF INTELLECTUAL PROPERTY

This technology is protected under US Patent 5,473,083


Ned Heindel's Lehigh Page


Innovation Details
 

Detailed Description

The invention features phototherapeutic compositions comprising Type 1, Type 2, or Type 3 psoralens and methods of using such compounds for treatment of proliferative diseases of skin, blood and bone marrow.

File Number: 090294-01 

Other Information: Inventors: "Ned Heindel":http://expert1.cc.lehigh.edu/LehighExperts/ExpertDetail.aspx?ExpertID=70055148"target=_blank Faculty Professor of Chemistry Licensing Opportunities: ● Exclusive ● Non-exclusive ● Research Sponsorship ● Product Development Partnerships (PDP) Contact Information: Office of Technology Transfer Lehigh University 354 Whitaker Laboratory 5 East Packer Ave. Bethlehem, PA 18015 Phone: (610) 758-5841 Fax: (610) 758-5888


IP Protection

Patent Number(s): 5473083

License Online

This innovation currently is not available for online licensing. Please contact Yatin Karpe at Lehigh University Office of Technology Transfer for more information.

Request more info via email request more info
People

Principal Investigator:

Ned Heindel Ned Heindel

Innovations (1)

Publications (5)


Case Manager:

Yatin Karpe Yatin Karpe

Innovations (59)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

4,590 members 13,287 innovations 113 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...